GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the
GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the merger, Mecon shareholders will receive 0.081 shares of GE stock for each share of Mecon stock held at the close of the merger, plus cash for any fractional shares. David Allinson, Mecons CFO, will assume the role of president and CEO, while Vasu Devan, president and CEO of Mecon since the company was founded, will continue in an advisory capacity.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.